Helix Technologies Inc. (fka HLIX)

[NobleRoman]

Legally Fox is not nor has ever been a board member.

Page 56: https://issuu.com/innovationandtech/docs/c_t_wint19_digital

Vincente Fox: "So here again, I am on the board of Helix."


It is not a subjective thing and why even Venegas himself said he has not actually been seated because duh it is legally verifiable.

Zac Venegas: "So Mr. Fox has agreed to be on our Board, but we haven’t empanelled him as yet because Mexico's cannabis program has slowed down significantly and we don't want to essentially get ahead of the curve by focusing a lot time and resources in Mexico when it's not quite ready for market development. So when that changes, we will make the appropriate entitlements. So there is that."

Source: https://seekingalpha.com/article/4335101-helix-tcs-inc-s-hlix-ceo-zachary-venegas-on-q4-2019-earnings-call-transcript


Rose like the original investor Greenfield is a stand alone PE shop. The biggest asset is a CPG branding company again unrelated to HLIX.

Helix Board Members:

https://www.streetinsider.com/SEC+Filings/Form+10-K+Helix+TCS%2C+Inc.+For%3A+Dec+31/15318982.html

"Andrew Schweibold, Director - Andrew is the Co-Founder and Managing Partner of Rose Capital...

..."SAT JOSHI BOARD MEMBER
Satyavrat “Sat” Joshi is the Chief Investment Officer of Rose Capital. Over the last 13 years.."

You love propaganda dontcha


See above and below.

It is understated as the biggest sellers have been Biotrack founders and toxic debt holders as they convert.

That part may be true and I do believe part of that. And I also believe the debt is toxic as I stated on the record. I believe KERN will find itself in that situation too as stated on the record. I have argued that HLIX was overvalued with the entire industry.

Then he also stated today:

"So with only a few hundred thousand left in cash plus a 450K judgement against Helix and he already sold Biotrack's receivable he did more toxic financing that will flood the market in a few months

Actually, there was a recent capital raise of about $1.2M. So, my math puts that at $1.6M. Less a settlement and 2 pending cases in appeals or in litigation. That recent round was not toxic.